Why the study?
Outcomes of patients with acute myocardial infarction-related cardiogenic shock stratified by SCAI shock stages in the Gulf region are not well known.
Does advanced SCAI shock stage (D/E) compared to earlier stages (B/C) predict worse survival in patients with acute myocardial infarction-related cardiogenic shock?
Does advanced SCAI shock stage (D/E) compared to earlier stages (B/C) predict worse survival in patients with acute myocardial infarction-related cardiogenic shock?
The SCAI shock staging classification effectively stratifies short- and long-term mortality risk in patients with acute myocardial infarction-related cardiogenic shock.
Answers are grounded in this paper and cite their sources.
May aid risk stratification in AMI shock; supports SCAI staging but leaves open prospective validation.
Background: Outcomes of patients with acute myocardial infarction-related cardiogenic shock (AMICS) stratified by the Society for Cardiovascular Angiography & Interventions (SCAI) shock stages in the Gulf region are not well known. Methods: We analyzed data from patients with AMICS presenting to multiple centers across the Gulf region between January 2020 and December 2022. Patients were grouped according to SCAI-Cardiogenic Shock Working Group classification: group 1 (SCAI shock stages B/C) and group 2 (SCAI shock stages D/E). Primary end points were survival at 6, 12, 18, and 24 months. Both univariate and multivariate statistical methods were employed in the analysis. Additionally, lower left ventricular ejection fraction, advanced age, and the presence of tachyarrhythmias were associated with increased mortality risk. Conclusions: This is the first study to validate SCAI-Cardiogenic Shock Working Group stages in a large cohort of patients with AMICS. The SCAI shock staging classification was significantly associated with higher short- and long-term mortality in this cohort, with patients in more advanced stages (D/E) experiencing markedly worse survival outcomes. These findings underscore the utility of SCAI staging in stratifying long-term risk among AMICS patients in the Gulf region. Identification of cardiogenic shock patients at SCAI stages D and E with early hemodynamic monitoring and treating them aggressively with newer mechanical circulatory support in the early stages may improve patient survival.
No takes yet. Share an insight, caveat, or question.
Rajan et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: